Insider Interview: Biosimilars to balance the books
July 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis
Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
Scotland approves first-line treatment for advanced kidney cancer
July 9, 2018Sales and Marketing Cancer, Scotland, fotivda, rcc, tivozanib
The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …
Regulus cuts workforce by 60%, halts studies in major restructure
July 9, 2018Sales and Marketing Regulus, pharma
California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part …
Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs
July 6, 2018Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia
As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …
Top Ten most popular articles on Pharmafile.com this week
July 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten
As the first week of July comes to an end we take a look over the most popular stories of …
Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%
July 6, 2018Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure
As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …
Missouri appeals court overturns $55m J&J verdict
July 6, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Litigation, appeal, pharma
A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in …
Illegally manufactured fentanyl drives deaths in Ontario
July 5, 2018Medical Communications Crisis, Ontario, canda, epidemic, fentanyl, opioid
Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of …
Ipsen reveals positive Phase 3 data of Cabometyx in liver cancer
July 5, 2018Research and Development Cabometyx, Cancer, ipsen, liver cancer, pharma
French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …
CHMP recommends Novartis’ CAR-T therapy Kymriah for EU approval
July 5, 2018Sales and Marketing CAR-T, CHMP, EMA, EU, Kymriah, Novartis, pharma
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) approve Novartis’ CAR-T …
Global animal health market set to be worth $44.2 billion by 2020
July 5, 2018Manufacturing and Production, Sales and Marketing Antibiotics, agriculture, animal, health, meat, pharma
The global animal health market is predicted to reach a value of $44.2 billion dollars by 2020, according to analysts …
Takeda to sell Osaka site to soften Shire deal’s financial impact
July 5, 2018Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma
It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …
NICE turns down BMS’ blockbuster Opdivo for urothelial carcinoma
July 5, 2018Sales and Marketing BMS, Bristol-Myers Squibb, NICE, opdivo, pharma, urothelial carcinoma
Just in time for the NHS’ 70th birthday, UK watchdog NICE has announced that it has taken the decision to …
Abivax drug lowers HIV DNA in blood and tissue, but has the opposite effect for some
July 4, 2018Research and Development Abivax, HIV, pharma
Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …
Review signals step towards legalisation of medicinal cannabis in UK
July 4, 2018Research and Development England, cannabis, pharma, review, thc
England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …
GSK Director indicted in Massachusetts opioid lawsuit
July 4, 2018Research and Development, Sales and Marketing
The state of Massachusetts has taken action to sue a board member at GlaxoSmithKline for her alleged role in fuelling …
The July/August issue of Pharmafocus is now live!
July 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Elizabeth Holmes, NHS, Sanofi, Theranos, UK, ambien, manufacturing compliance, opdivo, patient recruitment, patient retention, pharma
The new July/August edition of Pharmafocus is now available to read online.
Promising new drug slows Parkinson’s progression in mice
July 4, 2018Research and Development John Hopkins University, Parkinson's diabetes, pharma
Researchers from John Hopkins University have developed an experimental drug that slows the progression of Parkinson’s disease in mice. The …
Bayer expands Broad Institute partnership to focus on heart failure
July 3, 2018Manufacturing and Production, Research and Development Bayer, broad institute, collaboration, heart failure, pharma
The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …
Lundbeck appoints new President and CEO
July 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ludbeck, pharma
The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
